Atlas Trials

A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Clinical trial NCT01714843 · COMPLETED

Trial details

NCT number
NCT01714843
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Constipation-predominant Irritable Bowel Syndrome (IBS-C)
Start date
2012-08-10
Primary completion
2013-12-07
Enrollment
559

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.